SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001999371-24-001510 from Collaborative Investment Series Trust (CIK 0001719812)

Collaborative Investment Series Trust (CIK 0001719812)
Date: Feb. 5, 2024 · CIK: 0001719812 · Accession: 0001999371-24-001510

AI Filing Summary & Sentiment

File numbers found in text: 333-221072, 811-23306

Date
February 5, 2024
Author
/s/ Andrew Davalla
Form
CORRESP
Company
Collaborative Investment Series Trust (CIK 0001719812)

Letter

Division of Investment Management, Disclosure Review Office 3 World Financial Center New York, N.Y. 10281

Re: Collaborative Investment Series Trust, File Nos. 333-221072 and 811-23306

Dear Ms. Miller:

On December 14, 2023, you provided oral comments with respect to certain Securities and Exchange Commission filings of Greenwich Ivy Long-Short Fund (the “Fund”), a series of the Collaborative Investment Series Trust (the “Registrant”). Please find below the Fund’s response to those comments, which the Registrant has authorized Thompson Hine LLP to make on its behalf.

Comment 1: With respect to the performance chart disclosure in the Fund’s annual report to shareholders, please include disclosure that provides the Fund’s annual operating expense ratio (including any acquired fund fees and expenses) as set forth in the Fund’s most recent prospectus and consider providing a reference to the Fund’s financial highlights tp provide more current expense information.

Response: The Fund will include such disclosure in future shareholder report filings.

Comment 2: In the Fund’s financial statements in its annual report, please expand on the note regarding shorts sales to include details regarding the collateral and any fees associated with the borrowing of a security.

Response: The Fund will provide the requested information regarding any short sales in future shareholder reports.

Comment 3: Please include information in the Notes section of the shareholder reports to include disclosure, including amounts, regarding the Fund’s commitments and contingencies with respect to the Fund’s operating expense limitation agreement.

Response: The Fund will include such disclosure in future shareholder report filings.

If you have any questions or additional comments, please call Andrew Davalla at (216) 566-5706.

Sincerely,
/s/ Andrew Davalla

Show Raw Text
CORRESP
1
filename1.htm

February 5, 2024

Megan Miller

U.S. Securities and Exchange Commission

Division of Investment Management, Disclosure Review Office

3 World Financial Center

New York, N.Y. 10281

Re: Collaborative Investment Series Trust, File Nos. 333-221072 and 811-23306

Dear Ms. Miller:

On December 14, 2023, you provided oral comments
with respect to certain Securities and Exchange Commission filings of Greenwich Ivy Long-Short Fund (the “Fund”), a series
of the Collaborative Investment Series Trust (the “Registrant”). Please find below the Fund’s response to those comments,
which the Registrant has authorized Thompson Hine LLP to make on its behalf.

Comment 1: With respect to the performance
chart disclosure in the Fund’s annual report to shareholders, please include disclosure that provides the Fund’s annual operating
expense ratio (including any acquired fund fees and expenses) as set forth in the Fund’s most recent prospectus and consider providing
a reference to the Fund’s financial highlights tp provide more current expense information.

Response: The Fund will include such disclosure
in future shareholder report filings.

Comment 2: In the Fund’s financial statements
in its annual report, please expand on the note regarding shorts sales to include details regarding the collateral and any fees associated
with the borrowing of a security.

Response: The Fund will provide the requested
information regarding any short sales in future shareholder reports.

Comment 3: Please include information in the
Notes section of the shareholder reports to include disclosure, including amounts, regarding the Fund’s commitments and contingencies
with respect to the Fund’s operating expense limitation agreement.

Response: The Fund will include such disclosure
in future shareholder report filings.

If you have any questions or additional
comments, please call Andrew Davalla at (216) 566-5706.

  Sincerely,

  /s/ Andrew Davalla

  Andrew Davalla